Aigen Investment Management, LP Enanta Pharmaceuticals Inc Transaction History

Aigen Investment Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$41.02 - $58.65 $286,606 - $409,787	-6,987 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$43.76 - $53.11 $56,844 - $68,989	-1,299 Reduced 15.68%	6,987 $307,000
Q1 2021 May 11, 2021	SELL	$41.69 - $54.95 $190,439 - $251,011	-4,568 Reduced 35.54%	8,286 $409,000
Q4 2020 Feb 12, 2021	BUY	$41.16 - $47.47 $103,805 - $119,719	2,522 Added 24.41%	12,854 $541,000
Q3 2020 Nov 06, 2020	SELL	$43.36 - $53.53 $12,097 - $14,934	-279 Reduced 2.63%	10,332 $473,000
Q2 2020 Aug 10, 2020	SELL	$46.37 - $57.58 $640,879 - $795,813	-13,821 Reduced 56.57%	10,611 $533,000
Q1 2020 May 08, 2020	BUY	$40.22 - $62.0 $813,127 - $1.25 Million	20,217 Added 479.64%	24,432 $1.26 Million
Q4 2019 Feb 04, 2020	BUY	$57.95 - $66.61 $244,259 - $280,761	4,215 New	4,215 $260,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.